Skip to main content Help with accessibility Skip to main navigation

Aripiprazole

Indication

Treatment of Schizophrenia in adults. Treatment of Schizophrenia in people aged 15 to 17 years (NICE TA213)

NICE TA213 - Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
Amber level 1

Brand:

Abilify®

Nice TA:

213

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Recommended for the Treatment of Schizophrenia in adults by LSCMMG in line with Lancashire Care Foundation Trust Formulary.
Recommended for the Treatment of Schizophrenia in people aged 15 to 17 years in line with NICE TA 213.

Recommendation

LSCMMG Recommendation:

Amber level 1

Reason for decision:

Shared care required

Decisions of Lancashire local decision making groups

Pending
Pending
Amber 1
Pending
Amber 1
Amber 1
Amber 1
Amber 1
What do the colours mean?

Last Updated: 01 - May - 2013